PerClot
Device
CryoLife, Inc.
Total Payments
$3.4M
Transactions
245
Doctors
17
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2021 | $329.28 | 12 | 12 |
| 2020 | $144,749 | 30 | 0 |
| 2019 | $823,323 | 52 | 0 |
| 2018 | $1.8M | 107 | 1 |
| 2017 | $672,238 | 44 | 5 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $3.4M | 225 | 99.6% |
| Consulting Fee | $12,000 | 6 | 0.3% |
| Food and Beverage | $456.50 | 14 | 0.0% |
Payments by Type
Research
$3.4M
225 transactions
General
$12,457
20 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Prospective, Multicenter, Multidisciplinary, Controlled Clinical Investigation Evaluating the Safety and Efficacy of PerClot Polysaccharide Hemostatic System | CryoLife, Inc. | $3.4M | 0 |
| ON-X Aortic Prosthetic Heart Valve: Low dose Warfarin Post Approval | CryoLife, Inc. | $36,390 | 0 |
| Post-market, prospective evaluation of PHOTO-oxidized decellularized bovine pericardium used as a patch in Vascular repair and reconstruction surgery | CryoLife, Inc. | $10,418 | 0 |
Top Doctors Receiving Payments for PerClot
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Charleston, SC | $3.4M | 225 |
| , M.D | Urology | Atlanta, GA | $6,000 | 3 |
| , M.D | Transplant Surgery | New York, NY | $4,000 | 2 |
| , M.D | Specialist | St. Paul, MN | $2,000 | 1 |
| , M.D., PH.D | Cardiovascular Disease | Indianapolis, IN | $112.24 | 1 |
| Ismail El-Hamamsy | Thoracic Surgery (Cardiothoracic Vascular Surgery) | New York, NY | $27.44 | 1 |
| , MD | Thoracic Surgery (Cardiothoracic Vascular Surgery) | Cleveland, OH | $27.44 | 1 |
| , M.D | Thoracic Surgery (Cardiothoracic Vascular Surgery) | Cleveland, OH | $27.44 | 1 |
| , MD | Surgery | Los Angeles, CA | $27.44 | 1 |
| , M.D | Thoracic Surgery (Cardiothoracic Vascular Surgery) | Ann Arbor, MI | $27.44 | 1 |
| , MD | Thoracic Surgery (Cardiothoracic Vascular Surgery) | Corvallis, OR | $27.44 | 1 |
| , M.D | Thoracic Surgery (Cardiothoracic Vascular Surgery) | Plano, TX | $27.44 | 1 |
| , M.D | Surgery | Pgh., PA | $27.44 | 1 |
| , MD | Thoracic Surgery (Cardiothoracic Vascular Surgery) | Philadelphia, PA | $27.44 | 1 |
| , MD | Thoracic Surgery (Cardiothoracic Vascular Surgery) | Aurora, CO | $27.44 | 1 |
| Kyle Eudailey | Thoracic Surgery (Cardiothoracic Vascular Surgery) | Birmingham, AL | $27.44 | 1 |
| , MD | Thoracic Surgery (Cardiothoracic Vascular Surgery) | New York, NY | $27.44 | 1 |
| , D.O | Urology | Bradenton, FL | $14.98 | 1 |
Ad
Manufacturing Companies
- CryoLife, Inc. $3.4M
- Artivion, Inc. $329.28
Product Information
- Type Device
- Total Payments $3.4M
- Total Doctors 17
- Transactions 245
About PerClot
PerClot is a device associated with $3.4M in payments to 17 healthcare providers, recorded across 245 transactions in the CMS Open Payments database. The primary manufacturer is CryoLife, Inc..
Payment data is available from 2017 to 2021. In 2021, $329.28 was paid across 12 transactions to 12 doctors.
The most common payment nature for PerClot is "Unspecified" ($3.4M, 99.6% of total).
PerClot is associated with 3 research studies, including "Prospective, Multicenter, Multidisciplinary, Controlled Clinical Investigation Evaluating the Safety and Efficacy of PerClot Polysaccharide Hemostatic System" ($3.4M).